Neuphoria Therapeutics (NEUP) Non Operating Income (2023 - 2026)
Neuphoria Therapeutics' Non Operating Income was $586,666 in fiscal Q4 2026 (quarter ended Jun 30, 2026), compared with -$3.32 million a year earlier and down 12.7% from the prior quarter.
Powered by 
Analysis
Neuphoria Therapeutics (NEUP) Non Operating Income (2023 - 2026) Analysis & Trends
For FY2026 (ended Jun 30, 2026), Non Operating Income at Neuphoria Therapeutics came in at $2.86 million, up 882.5% from FY2025.
- Non Operating Income shows a three-year compound annual growth rate of 83.6% (FY2023 to FY2026).
- In earlier fiscal years, Non Operating Income was $291,093 in FY2025 (-87.4%), $2.31 million in FY2024 (+400.5%) and $462,125 in FY2023.
- Quarterly Non Operating Income has moved between -$4.29 million (fiscal Q1 2026) and $5.89 million (fiscal Q2 2026) over five years.
- Per Business Quant data, NEUP's Non Operating Income in the three fiscal quarters before Q4 2026 was $671,793 (Q3 2026), $5.89 million (Q2 2026) and -$4.29 million (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 269.00 Mn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | - |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | - |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | - |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | -73.00 Mn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 387.00 Mn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | - |
| 10 | Neuphoria Therapeutics | 435.69 Mn | 360.50 Mn | - | 586,666.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 586,666.00 |
| Mar 31, 2026 | 671,793.00 |
| Dec 31, 2025 | 5.89 Mn |
| Sep 30, 2025 | -4.29 Mn |
| Jun 30, 2025 | -3.32 Mn |
| Mar 31, 2025 | -796,218.00 |
| Dec 31, 2024 | 1.77 Mn |
| Sep 30, 2024 | 2.63 Mn |
| Jun 30, 2024 | 2.76 Mn |
| Mar 31, 2024 | -367,734.00 |
| Dec 31, 2023 | -36,356.00 |
| Sep 30, 2023 | -39,754.00 |
API Access
Neuphoria Therapeutics Non Operating Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-income&ticker=NEUP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-income", "ticker": "NEUP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-income&ticker=NEUP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();